Watson Pharma (WPI) Receives FTC Nod for Actavis Acquisition

October 15, 2012 5:19 PM EDT Send to a Friend
Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the Federal Trade Commission (FTC) has voted to approve Watson's acquisition of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login